Ming‐Dauh Wang

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	An evaluation of the trimmed mean approach in clinical trials with dropout	2018	Ming‐Dauh Wang Jiajun Liu Geert Molenberghs Craig Mallinckrodt
+	Bayesian Modeling of Time Response and Dose Response for Predictive Interim Analysis of a Clinical Trial	2016	Ming‐Dauh Wang Dominique A. Williams Elisa Gómez Jyoti N. Rayamajhi
+	Incorporating Biomarkers Into the Analysis of Preclinical Cardiovascular Safety Studies	2015	Alan Y. Chiang Ming‐Dauh Wang
+	Applications of Probability of Study Success in Clinical Drug Development	2015	Ming‐Dauh Wang
+	Bayesian Interim Inference of Probability of Clinical Trial Success	2013	Ming‐Dauh Wang Grace Ying Li
+	A Multivariate Ranking Procedure to Assess Treatment Effects	2008	Alan Y. Chiang Grace Li Ming‐Dauh Wang
+	Sample Size Reestimation by Bayesian Prediction	2007	Ming‐Dauh Wang
+	Sample Size Reestimation by Bayesian Prediction	2006	Ming‐Dauh Wang
+	Bayesian predictive approach to interim monitoring in clinical trials	2005	Alexei Dmitrienko Ming‐Dauh Wang
+	Optimal dichotomization of screening test variables	2004	Ming‐Dauh Wang Seymour Geisser
+	Optimal dichotomization for repeated screening tests	2003	Ming‐Dauh Wang Seymour Geisser
+	On the Optimal Administration of Multiple Screening Tests	1999	Ming‐Dauh Wang Seymour Geisser

Common Coauthors

Coauthor	Papers Together
Seymour Geisser	3
Alan Y. Chiang	2
Geert Molenberghs	1
Craig Mallinckrodt	1
Grace Ying Li	1
Jyoti N. Rayamajhi	1
Grace Li	1
Elisa Gómez	1
Jiajun Liu	1
Dominique A. Williams	1
Alexei Dmitrienko	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Bayesian predictive approach to interim monitoring in clinical trials	2005	Alexei Dmitrienko Ming‐Dauh Wang	6
+	On the curtailment of sampling	1992	Seymour Geisser	4
+	Monitoring clinical trials: Conditional or predictive power?	1986	David J. Spiegelhalter Laurence S. Freedman Patrick R. Blackburn	3
+ PDF Chat	Statistical Approaches to Interim Monitoring of Medical Trials: A Review and Commentary	1990	Christopher Jennison Bruce W. Turnbull	3
+	Monitoring Clinical Trials Based on Predictive Probability of Significance	1989	Sung C. Choi Patricia A. Pepple	3
+	Early decision in clinical trials when the treatment differences are small	1985	Sung C. Choi Philip J Smith Donald P. Becker	3
+	Designed Extension of Studies Based on Conditional Power	1995	Michael A. Proschan Sally Hunsberger	3
+	Sample size re‐estimation in cluster randomization trials	2002	Stephen Lake Erin Kammann Neil Klar Rebecca A. Betensky	2
+ PDF Chat	A sample size adjustment procedure for clinical trials based on conditional power	2002	G. Li	2
+	Monte Carlo Minimization for One Step Ahead Sequential Control	1999	Li-Shya Chen Seymour Geisser Charles J. Geyer	2
+	Sample size and the probability of a successful trial	2006	Christy Chuang‐Stein	2
+	Blinded sample size reassessment in non‐inferiority and equivalence trials	2003	Tim Friede Meinhard Kieser	2
+	On Dependent Repeated Screening Tests	1991	Tak-Wing Lau	2
+	Issues in designing flexible trials	2003	Martin Posch Péter Bauer Werner Brannath	2
+	Group sequential, sample size re‐estimation and two‐stage adaptive designs in clinical trials: a comparison	2005	Weichung Joe Shih	2
+	Constrained Monte Carlo Maximum Likelihood for Dependent Data	1992	Charles J. Geyer E. A. Thompson	2
+	Sample size re‐estimation: recent developments and practical considerations	2001	A. Lawrence Gould	2
+	Bayesian Adaptive Dose-Finding Studies with Delayed Responses	2010	Haoda Fu David H. Manner	2
+	The reassessment of trial perspectives from interim data—a critical view	2005	Péter Bauer Franz Koenig	2
+	A Quantitative Approach for Making Go/No-Go Decisions in Drug Development	2011	Christy Chuang‐Stein Simon Kirby Jonathan French Ken Kowalski Scott Marshall Michael K. Smith Paul Bycott Mohan Beltangady	2
+	Sample-Size Redetermination for Repeated Measures Studies	2002	David M. Zucker Jonathan Denne	2
+	The what, why and how of bayesian clinical trials monitoring	1994	Laurence S. Freedman David J. Spiegelhalter Mahesh Parmar	2
+ PDF Chat	On the Convergence of Monte Carlo Maximum Likelihood Calculations	1994	Charles J. Geyer	2
+	Reliability, Decision Rules, and the Value of Repeated Tests	1982	P Politser	2
+	A Bayesian perspective on the Bonferroni adjustment	1997	Peter H. Westfall Wesley O. Johnson Jessica Utts	2
+	On the inefficiency of the adaptive design for monitoring clinical trials	2003	Anastasios A. Tsiatis	2
+	Sample size re‐estimation – journey for a decade	2001	Weichung Joseph Shih	2
+	Comparing two tests used for diagnostic or screening purposes	1998	Seymour Geisser	2
+	Sample Size Reestimation by Bayesian Prediction	2007	Ming‐Dauh Wang	2
+ PDF Chat	A Class of Statistics with Asymptotically Normal Distribution	1992	Wassily Hoeffding	1
+	Bayesian Analysis of Constrained Parameter and Truncated Data Problems Using Gibbs Sampling	1992	Alan E. Gelfand A. F. M. Smith Tai-Ming Lee	1
+	Bayesian Statistics in Medical Devices: Innovation Sparked by the FDA	2011	Gregory Campbell	1
+	The Analysis of Multiple Endpoints in Clinical Trials	1987	Stuart J. Pocock Nancy L. Geller Anastasios A. Tsiatis	1
+	Optimal dichotomization for repeated screening tests	2003	Ming‐Dauh Wang Seymour Geisser	1
+	Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis	1994	S. Pampallona Anastasios A. Tsiatis	1
+ PDF Chat	A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models	2002	Alan E. Gelfand Fei Wang	1
+	Bayesian Semiparametric Predictive Modeling with Applications in Dose-Response Prediction	2014	Ben Haaland Alan Y. Chiang	1
+	Evaluating and utilizing probability of study success in clinical development	2013	Yanping Wang Haoda Fu Pandurang M. Kulkarni Christopher Kaiser	1
+ PDF Chat	Use of historical control data for assessing treatment effects in clinical trials	2013	Kert Viele Scott Berry Beat Neuenschwander Billy Amzal Fang Chen Nathan Enas Brian P. Hobbs Joseph G. Ibrahim Nelson Kinnersley Stacy Lindborg	1
+ PDF Chat	Meta-Analysis of Clinical Dose–Response in a Large Drug Development Portfolio	2014	Neal Thomas Kevin Sweeney Veena Somayaji	1
+	A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data	1989	Sam Wieand Mitchell H. Gail Barry R. James Kang Ling James	1
+	Seamlessly Expanding a Randomized Phase II Trial to Phase III	2002	Lurdes Y. T. Inoue Peter F. Thall Donald A. Berry	1
+	Assurance in clinical trial design	2005	Anthony O’Hagan John Stevens Michael J. Campbell	1
+ PDF Chat	Recent Developments in the Prevention and Treatment of Missing Data	2013	Craig Mallinckrodt James Roger Christy Chuang‐Stein Geert Molenberghs Michael O’Kelly Bohdana Ratitch Marcel Janssens Pierre Bunouf	1
+ PDF Chat	Markov Chains for Exploring Posterior Distributions	1994	Luke Tierney	1
+	Procedures for Comparing Samples with Multiple Endpoints	1984	Peter C. O’Brien	1
+	Practical Bayesian Design and Analysis for Drug and Device Clinical Trials	2007	Brian P. Hobbs Bradley P. Carlin	1
+	Bayesian estimates of predictive value and related parameters of a diagnostic test	1992	Marios A. G. Viana Viswanathan Ramakrishnan	1
+	Robust Bayesian sample size determination in clinical trials	2008	Pierpaolo Brutti Fulvio De Santis Stefania Gubbiotti	1
+ PDF Chat	Statistical design and monitoring of the carotene and retinol efficacy trial (CARET)	1993	Mark Thornquist Gilbert S. Omenn Gary E. Goodman James E. Grizzle Linda Rosenstock Scott Barnhart Garnet L. Anderson Samuel P. Hammar John R. Balmes Martin G. Cherniack	1